FilingSEC EDGAR10-K
Rezolute Files Fiscal 2026 Annual Report
· SEC accepted
StagePhase 3
Filing content
The company reported the streamlining of its Phase 3 upLIFT study to a single-arm, open-label trial and disclosed capital resources of $107.8 million as of June 30, 2026.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…